Science

Jun 13, 2025, 09:06

Myeloma Paper of the Day, June 13th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: German analysis of 343 triple-class exposed relapsed/refractory patients who received ide-cel or cilta-cel finds cilta with higher CR rate (61% vs. 39%) and improved response conversion with more CRs after starting from <CR pre-CAR.”

Title: Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST

Authors: Maximilian Merz, Nico Gagelmann, Samih Smaili, Sarah Flossdorf, Sandra Sauer, Christof Scheid, Bastian von Tresckow, Gerald Georg Wulf, Katja C Weisel, Igor Blau, Monika Engelhardt, Ralph Wäsch, Natalie Schub, Raphael Teipel, Judith S. Hecker, Johannes M. Waldschmidt, Britta Besemer, Ben-Niklas Baermann, Simon Call, Leo Hansmann, Francis Ayuketang Ayuk, Marc S. Raab, Hermann Einsele, Uwe Platzbecker, Nicolaus Kröger

You can read the Full Article in Blood.

More posts featuring Robert Orlowski.

cancer Christof Scheid Francis Ayuketang Ayuk Hermann Einsele Marc S. Raab Maximilian Merz multiple myeloma Myeloma Paper of the Day Nico Gagelmann Nicolaus Kröger OncoDaily Oncology Robert Orlowski RRMM Samih Smaili Sandra Sauer Sarah Flossdorf Uwe Platzbecker

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More

Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology

How Artificial Intelligence Is Transforming Cancer Care in 2025: Diagnosis, Treatment, Clinical Trials, and Screening

Inside ASCO25 Exhibition - Who did it the best?